Power Law company profile

Pear Therapeutics

Biotech & Life Sciences · Boston, United States · Founded 2013 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$690K

Market cap · 2026

Revenue

$13M

Latest reported FY

Investors

13 investors on Pear Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 5 investors entered at this stage

Novartis

Bridge Builders Collaborative

JAZZ Venture Partners

Arboretum Ventures

5AM Ventures

Series B+ 8 investors entered at this stage

EDBI

Shanda Group

QUAD Investment Management

Global footprint

Where Pear Therapeutics has talent and traffic

Web traffic by country

410 monthly visits
across markets

🇪🇬 Egypt97.6%

Top 1 markets shown

Patent intelligence

$9M patent portfolio · 8 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$9M

1348.7% of market cap · 761.4× smaller than top peer Janssen Vaccines ($7.1B)

8 active patent families

Where Pear Therapeutics innovates Data processingElectronic equipmentPharmacologyInternal medicineBehavioral therapy

Below peer median on Legal, Strategic, Economic

Quality vs same-sector peers

Pear Therapeutics on the five Patsnap quality dimensions

Pear Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Pear Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Pear Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Pear Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo